Opportunity Information: Apply for CDC RFA DD15 1501
Apply for CDC RFA DD15 1501
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhancing Public Health Surveillance of Autism Spectrum Disorder and Other Developmental Disabilities through the Autism and Developmental Disabilities Monitoring (ADDM) Network" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.998 Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention.
- This funding opportunity was created on Oct 1, 2014 and posted on Aug 6, 2014.
- Applicants must submit their applications by Oct 10, 2014 Dates 1. Letter of Intent (LOI) Deadline September 12, 2014 2. Application Deadline October 10, 2014, 1159 p.m. U.S. Eastern Standard Time, on www.grants.gov 3. Informational conference call for potential applicants August 29, 2014 at 100 p.m. U.S. Eastern Standard Time, Toll Free 888 622 8609 Participant Passcode 7180491. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $25,300,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $475,000.00 in funding.
- The number of recipients for this funding is limited to 14 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility Information Eligible applicants for this FOA are included in this section. Eligible Applicants Government Organizations States or their bona fide agents (includes the District of Columbia) Local governments or their bona fide agents Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) State controlled institutions of higher education American Indian or Alaska Native tribal governments (federally recognized or state recognized) Public Housing Authorities/Indian Housing Authorities Non government Organizations American Indian or Alaska native tribally designated organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Private colleges and universities Community based organizations Faith based organizations For profit organizations (other than small business) Small businesses
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (CDC-RFA-DD15-1501) is a discretionary cooperative agreement designed to strengthen and expand public health surveillance for autism spectrum disorder (ASD) and related developmental disabilities through participation in the Autism and Developmental Disabilities Monitoring (ADDM) Network. The overall goal is to boost the ability of funded sites to run (or improve) a population-based surveillance system that pulls from multiple data sources, so communities can get more accurate, comparable estimates of how common ASD is, how it varies across groups, and how it changes over time. In addition to ASD, the FOA emphasizes monitoring other developmental disabilities that often co-occur with ASD, specifically cerebral palsy (CP) and intellectual disability (ID).
The program is organized into two components. Component A is mandatory for all applicants and funds surveillance of ASD as well as CP and ID among 8-year-old children, which is a key ADDM age group for tracking prevalence and characteristics consistently across sites. Component B is optional and provides additional funding to conduct ASD surveillance among 4-year-old children, which supports earlier-age monitoring and can help public health programs understand identification patterns closer to the time when children may first be evaluated or diagnosed. Sites can apply for Component A alone or for both Component A and Component B, but cannot apply only for Component B.
The FOA lays out five short-term outcomes that CDC expects to achieve over the project period, along with strategies and activities tied to each outcome. First, it aims to improve understanding of ASD and other developmental disabilities by producing stronger estimates of prevalence and by documenting trends and disparities, such as differences by race/ethnicity, sex, geography, or other factors that can reflect unequal access to evaluation and services. Second, it specifically targets improved understanding of what it means to shift from DSM-IV-TR to DSM-5 diagnostic criteria for ASD, since changes in diagnostic standards can affect who is counted as having ASD in surveillance data and can complicate comparisons across years. Third, the FOA prioritizes building stronger relationships with partners and data sources, reflecting the reality that high-quality, multiple-source surveillance depends on stable access to records and sustained collaboration with schools, clinics, and other systems. Fourth, it emphasizes increased dissemination of ADDM data so findings are more effectively communicated to stakeholders, including public health leaders, policymakers, educators, clinicians, and communities. Fifth, it focuses on improving the reliability and efficiency of ADDM surveillance, meaning better standardization, consistency, and operational performance across sites so the network can produce dependable, comparable results.
Operationally, the opportunity anticipates funding 14 awards with an estimated total funding level of $25.3 million. Individual awards are expected to fall within a relatively narrow range, with a floor of $425,000 and a ceiling of $475,000. Because this is a cooperative agreement, awardees should expect substantial involvement from CDC beyond what is typical in a standard grant, often including technical guidance, shared protocols, network coordination, and expectations for consistent methods across participating sites. The FOA does not require cost sharing or matching.
Eligibility is broad and includes many types of organizations that can support population-based surveillance and data partnerships. Eligible applicants include state, local, and territorial governments and their bona fide agents (including the District of Columbia and multiple U.S. territories), state-controlled institutions of higher education, federally or state-recognized tribal governments, and public housing authorities/Indian housing authorities. Non-government entities are also eligible, including tribally designated organizations, nonprofits with or without 501(c)(3) status (other than institutions of higher education), private colleges and universities, community-based and faith-based organizations, for-profit organizations (other than small businesses), and small businesses. This wide eligibility reflects that ADDM sites may be housed in health departments, universities, or other organizations capable of managing data use agreements, coordinating with multiple systems, and conducting standardized surveillance.
Key administrative details include that the FOA was posted on August 6, 2014, with a letter of intent deadline of September 12, 2014, and a full application deadline of October 10, 2014 at 11:59 p.m. Eastern Time via Grants.gov. CDC also scheduled an informational conference call for potential applicants on August 29, 2014. The opportunity was later archived on November 9, 2014. For technical access issues with the announcement, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) (phone 770-488-2700; email pgotim@cdc.gov).
In practical terms, this FOA is about building a stronger, more coordinated surveillance infrastructure that can answer essential public health questions: how many children are affected by ASD and co-occurring conditions like CP and ID, whether identification and prevalence differ across communities, how diagnostic rule changes influence surveillance counts, and how to share findings in ways that support planning for services and interventions. The ADDM Network structure is central to the design, since it enables standardized methods and cross-site comparisons rather than isolated, non-comparable local estimates.
Frequently Asked Questions (FAQs)
What is CDC-RFA-DD15-1501?
CDC-RFA-DD15-1501 is a CDC discretionary cooperative agreement funding opportunity to strengthen and expand public health surveillance for autism spectrum disorder (ASD) and related developmental disabilities through participation in the Autism and Developmental Disabilities Monitoring (ADDM) Network.
What is the main goal of this funding opportunity?
The overall goal is to improve the ability of funded sites to run (or enhance) a population-based surveillance system that uses multiple data sources, so communities can get more accurate and comparable estimates of how common ASD is, how it varies across groups, and how it changes over time.
Which conditions are included in the surveillance work?
The FOA focuses on ASD and also emphasizes monitoring other developmental disabilities that often co-occur with ASD, specifically cerebral palsy (CP) and intellectual disability (ID).
What is the ADDM Network and why does it matter here?
The ADDM Network is the structure used to support standardized surveillance methods and cross-site comparisons. The FOA is designed around ADDM participation so results are comparable across funded sites rather than isolated local estimates.
How is the program structured?
The program has two components. Component A is required for all applicants. Component B is optional and provides additional funding for an expanded surveillance activity focused on a younger age group.
What is Component A?
Component A is mandatory and funds surveillance of ASD as well as CP and ID among 8-year-old children. This age group is described as a key ADDM age group for tracking prevalence and characteristics consistently across sites.
What is Component B?
Component B is optional and provides additional funding to conduct ASD surveillance among 4-year-old children. This supports earlier-age monitoring and can help public health programs understand identification patterns closer to when children may first be evaluated or diagnosed.
Can an applicant apply for only Component B?
No. Sites may apply for Component A alone or for both Component A and Component B, but they cannot apply only for Component B.
What age groups are specifically mentioned in the FOA?
The FOA specifically references surveillance among 8-year-old children under Component A, and optional ASD surveillance among 4-year-old children under Component B.
What outcomes does CDC expect from this program?
The FOA describes five short-term outcomes expected over the project period: (1) improved understanding of ASD and other developmental disabilities through stronger prevalence estimates and documentation of trends and disparities; (2) improved understanding of the impact of shifting diagnostic criteria from DSM-IV-TR to DSM-5; (3) stronger relationships with partners and data sources; (4) increased dissemination of ADDM data to stakeholders; and (5) improved reliability and efficiency of ADDM surveillance through better standardization and operational performance across sites.
What kinds of disparities or differences is the surveillance intended to examine?
The FOA highlights examining differences and disparities such as variations by race/ethnicity, sex, geography, or other factors that may reflect unequal access to evaluation and services.
Why does the FOA mention DSM-IV-TR versus DSM-5?
The FOA prioritizes understanding how the shift from DSM-IV-TR to DSM-5 diagnostic criteria for ASD affects surveillance. Changes in diagnostic standards can influence who is counted as having ASD and can complicate comparisons across years.
Why are partnerships and multiple data sources emphasized?
The FOA notes that high-quality, multiple-source surveillance depends on stable access to records and sustained collaboration with partners and data sources such as schools, clinics, and other systems.
Who are the intended audiences for dissemination of ADDM data?
The FOA emphasizes communicating findings effectively to stakeholders including public health leaders, policymakers, educators, clinicians, and communities.
What does “improving reliability and efficiency” mean in this context?
In this FOA, it refers to better standardization, consistency, and operational performance across sites so the network can produce dependable, comparable results.
How many awards does CDC anticipate making?
The opportunity anticipates funding 14 awards.
What is the estimated total funding level?
The estimated total funding level is $25.3 million.
What is the expected award amount per recipient?
Individual awards are expected to fall within a relatively narrow range, with a floor of $425,000 and a ceiling of $475,000.
Is cost sharing or matching required?
No. The FOA states that cost sharing or matching is not required.
What does it mean that this is a cooperative agreement?
As a cooperative agreement, awardees should expect substantial CDC involvement beyond what is typical in a standard grant. The FOA describes involvement such as technical guidance, shared protocols, network coordination, and expectations for consistent methods across participating sites.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include state, local, and territorial governments and their bona fide agents (including the District of Columbia and U.S. territories), state-controlled institutions of higher education, federally or state-recognized tribal governments, and public housing authorities/Indian housing authorities. Eligible non-government entities include tribally designated organizations; nonprofits with or without 501(c)(3) status (other than institutions of higher education); private colleges and universities; community-based and faith-based organizations; for-profit organizations (other than small businesses); and small businesses.
Are colleges and universities eligible?
Yes. The FOA lists state-controlled institutions of higher education and private colleges and universities as eligible applicant types.
Are nonprofits eligible even if they do not have 501(c)(3) status?
Yes. The FOA states that nonprofits with or without 501(c)(3) status (other than institutions of higher education) are eligible.
Are for-profit organizations eligible?
Yes. The FOA includes for-profit organizations (other than small businesses) as eligible, and also separately lists small businesses as eligible.
Are tribal entities eligible?
Yes. The FOA includes federally or state-recognized tribal governments and tribally designated organizations as eligible applicants.
When was the FOA posted?
The FOA was posted on August 6, 2014.
Was a letter of intent required, and when was it due?
The FOA included a letter of intent deadline of September 12, 2014.
When was the full application due and how was it submitted?
The full application deadline was October 10, 2014 at 11:59 p.m. Eastern Time, and submission was via Grants.gov.
Did CDC offer an informational call for applicants?
Yes. CDC scheduled an informational conference call for potential applicants on August 29, 2014.
What does it mean that the opportunity was archived?
The FOA was later archived on November 9, 2014, indicating it is no longer an active funding announcement.
Who should applicants contact for technical access issues with the announcement?
For technical access issues, CDC directed applicants to the Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700 or pgotim@cdc.gov.
In practical terms, what public health questions is this program meant to answer?
The FOA frames the work as building a stronger, coordinated surveillance infrastructure to answer questions such as: how many children are affected by ASD and co-occurring conditions like CP and ID; whether identification and prevalence differ across communities; how diagnostic rule changes influence surveillance counts; and how to share findings to support planning for services and interventions.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Notice of Intent to Award Sudbury, Assabet and Concord Wild and Scenic River Assistance
Previous opportunity: Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD15 1501
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD15 1501) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Indian Health Outreach and Education II Apply for HHS 2014 IHS NIHOE 0002 Funding Number: HHS 2014 IHS NIHOE 0002 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| Collaborative Partnership on Alcohol and Health Disparity Research Center (ADHRC) (U54) Apply for RFA AA 15 003 Funding Number: RFA AA 15 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID/Ghana Communicate for Health Apply for RFA 641 14 000001 Funding Number: RFA 641 14 000001 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,000,000 |
| Nathan Shock Centers of Excellence in Basic Biology of Aging (P30) Apply for RFA AG 15 005 Funding Number: RFA AG 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Immunization and Vaccines for Children Program Apply for CDC RFA IP13 130103CONT15 Funding Number: CDC RFA IP13 130103CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Role of the Microbiome in HIV 1 Vaccine Responses (R01) Apply for PAR 14 317 Funding Number: PAR 14 317 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Role of the Microbiome in HIV 1 Vaccine Responses (R21) Apply for PAR 14 318 Funding Number: PAR 14 318 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) Apply for HRSA 15 005 Funding Number: HRSA 15 005 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition NIGMS National Centers for Systems Biology (P50) Apply for PAR 14 319 Funding Number: PAR 14 319 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Administrative Supplements for Tobacco Regulatory Research on the Role and Impact of Flavors in Cigarettes, Cigars, E Cigarettes and Smokeless Tobacco (Admin Supp) Apply for PA 14 320 Funding Number: PA 14 320 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for Affordable Care Act Consumer Assistance Program Grants Apply for CA CAP 14 001 Funding Number: CA CAP 14 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: $442,863 |
| Research Planning Infrastructure to Develop Therapeutic Target ID Strategies Based on Favorable Genetic Variants of Human Longevity or Health Span (U24) Apply for RFA AG 15 014 Funding Number: RFA AG 15 014 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp) Apply for PA 14 322 Funding Number: PA 14 322 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening Mozambican Capacity in Strategic Information Systems in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1563 Funding Number: CDC RFA GH15 1563 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) (U01) Apply for RFA HL 15 016 Funding Number: RFA HL 15 016 Agency: National Institutes of Health Category: Health Funding Amount: $3,300,000 |
| Multi Site Clinical Trials for the Pulmonary Trials Cooperative (PTC) (U01) Apply for RFA HL 15 015 Funding Number: RFA HL 15 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 15 007 Funding Number: RFA AG 15 007 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Recovery Best Practices Apply for EP HIT 14 002 Funding Number: EP HIT 14 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $90,000 |
| Laboratory Systems Strengthening Services to Countries in the Southeast Asia and Pacific Regions Supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1536 Funding Number: CDC RFA GH15 1536 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| MD PhD Training Program in Aging and the Social/Behavioral Sciences (T32) Apply for RFA AG 15 012 Funding Number: RFA AG 15 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD15 1501", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.